Prof Shai Izraeli speaks with ecancertv at BSH 2016 about the landscape of childhood leukaemia.

With the majority of childhood cases of ALL being curable, Prof Izraeli outlines avenues for further research: treating high-risk groups and reducing toxicity with targeted therapy. 

He also addresses the clinical significance of genomic data for risk stratification and therapy identification.